SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

Raymond James Downgrades Leap Therapeutics to Market Perform

Raymond James downgrades Leap Therapeutics (NASDAQ:LPTX) from Outperform to Market Perform.

Benzinga · -

Raymond James downgrades Leap Therapeutics (NASDAQ:LPTX) from Outperform to Market Perform.